Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
Aeolus Pharmaceuticals Inc. Stock Analysis AOLS
United States Health Care Nano Cap Aeolus Pharmaceuticals, Inc. is a pharmaceutical company, which engages in developing a portfolio of novel metalloporphyrins. AEOL-10150 is catalytic antioxidant compound based on technology developed at Duke University and National Jewish Health. These compounds, known as metalloporphyrins, scavenge reactive oxygen species at the cellular level, mimicking the effect of the body’s own natural antioxidant enzyme superoxide dismutase. The Company’s products include AEOL 10150, AEOL 11207, and ED-Customer.com. The company also has two programs underway for the development of its second drug candidate, AEOL 11207, for the treatment of epilepsy and Parkinson’s disease. Its AEOL 10150 product includes catalytic antioxidant program, which is designed to retain the catalytic mechanism and high antioxidant efficiency of the natural enzymes and create and develop stable and small molecule antioxidants without the limitations of superoxide dismutase.
Read More Aeolus Pharmaceuticals Inc (AOLS) Chart
Key Statistics of Aeolus Pharmaceuticals Inc (AOLS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
100.00P/E Ratio (TTM)
-52 Week Range
Market Cap
15.21KAvg. Volume
25.05KDividend Yield
-Financial Metrics & Statements of Aeolus Pharmaceuticals Inc (AOLS)
FAQ's for Aeolus Pharmaceuticals Inc (AOLS)
- According to Musaffa’s Shariah screening methodology, Aeolus Pharmaceuticals Inc (AOLS) is currently classified as NOT COVERED as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Aeolus Pharmaceuticals Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Aeolus Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Aeolus Pharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Aeolus Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Aeolus Pharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.